About Maiva Pharma Private Limited
Data last updated:
Maiva Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of G A Global Pte. Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 February 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA1993PTC013976. Its GSTIN is 33AAACG5033G1Z4 (Tamil Nadu). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹31.03 Cr and a paid-up capital of ₹24.66 Cr. It was formerly known as Carodian Private Limited and Global Pharmatech Private Limited. It is led by directors including Arumugam Bhaskar Krishna (Managing Director) and Janardhan (Whole-Time Director).
Its last annual general meeting (AGM) was held on 31 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹399.05 Cr, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹77.08 Cr (net margin 19.3%) and EBITDA of ₹127.3 Cr (EBITDA margin 31.9%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 49% over five years.
The company has about 751 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Maiva Pharma. As per MCA filings, the company has open charges of ₹822 Cr and satisfied charges of ₹24.1 Cr on record. Court records list 51 cases involving the company, including 32 filed by the company and 14 filed against it; 4 cases are pending. The company has 31 deals on record (20 secondary share transfers, 11 funding rounds), with disclosed funding of ₹482.8 Cr; the latest was in June 2024. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Mascot Health Series Private Limited. with revenue of ₹404.31 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2023, listing 134 overdue payments to 22 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maivapharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressNo. 705 2nd Floor Om Shree Mnv Towers, 5th Block Hmt Layout Vidyaranyapura Main Road, Bangalore, Karnataka, India – 560097
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Maiva Pharma Private Limited
The main business activity of Maiva Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Maiva Pharma Private Limited FY 2025 filings available
Maiva Pharma Private Limited reported revenue of ₹399.05 Cr (up 38% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Maiva Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 49% over five years, including 38% growth in the latest year. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Maiva Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹127.3 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹77.08 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Maiva Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 19.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maiva Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Maiva Pharma Private Limited
Maiva Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mascot Health Series Private Limited. | ₹404.31 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Torque Pharmaceuticals Private Limited | ₹404.13 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Chandigarh, India |
| Steril-Gene Life Sciences Private Limited | ₹404.06 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Chennai, Tamil Nadu, India |
| Zeiss Pharmaceuticals Private Limited | ₹403.65 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Nalagarh, Himachal Pradesh, India |
| Gland Chemicals Pvt Ltd | ₹401.18 Cr (FY 2022) | •••• | •••• | 33.0% | •••• | Hyderabad, Telangana, India |
| Maiva Pharma Private Limited this company | ₹399.05 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Bangalore, Karnataka, India |
| Martin & Harris Private Limited | ₹398.47 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | New Delhi, Delhi, India |
| Novartis India Limited Listed | ₹398.23 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| Rusan Pharma Limited | ₹392.15 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Hetero Biopharma Limited | ₹387.48 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Hyderabad, Telangana, India |
| Zim Laboratories Limited. Listed | ₹384.82 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Nagpur, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Maiva Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Maiva Pharma Private Limited
Maiva Pharma Private Limited is audited by MSKA & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MSKA & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Maiva Pharma Private Limited
Maiva Pharma has 5 current directors and 24 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nirav Vinod Mehta Also directs: Maiva Lifesciences Private Limited, Fullife Healthcare Private Limited, R.G. Scientific Enterprises Private Limited and 3 more | Director | 30 Apr 2024 | 2 Years 5 Months | Current |
| Janardhan Also directs: Maiva Lifesciences Private Limited | Whole-Time Director | 25 Aug 2021 | 5 Years 1 Months | Current |
| Arumugam Bhaskar Krishna | Managing Director | 27 May 2013 | 13 Years 4 Months | Current |
| Buggana Hariharnath Also directs: Invascent Advisory Services India LLP, Invascent Ilsf Manager LLP, Symbiotec Zenfold Private Limited and 5 more | Director | 13 Sep 2024 | 2 Years 0 Months | Current |
| Vaibhav Bagri | Director | 31 Jul 2024 | 2 Years 2 Months | Current |
Ownership and Shareholding of Maiva Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maiva Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2025 | Others | ₹500 Cr | Open |
| 20 Oct 2020 | Hdfc Bank Limited | ₹198 Cr | Open |
| 11 Sep 2020 | Hdfc Bank Limited | ₹124 Cr | Open |
| 20 Oct 2020 | Hdfc Bank Limited | ₹20 Cr | Satisfied |
| 25 Mar 2002 | Indian Bank | ₹1.6 Cr | Satisfied |
Total charge records: 6 View all charges
Deals & Funding of Maiva Pharma Private Limited
Maiva Pharma Private Limited has 31 deals on record (20 secondary share transfers, 11 funding rounds), with disclosed funding of ₹482.8 Cr; the latest was in June 2024.
Deals on record (5 of 31)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2019 | Secondary share transfer | Undisclosed | Buyer: G A Global Pte Limited Seller: Exodus Technologies Private Limited |
| Jul 2019 | Secondary share transfer | Undisclosed | Buyer: AGP Global Health Care LLP, an individual Seller: Accusoft Technologies Private Limited , an individual |
| Jun 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Accusoft Technologies Private Limited |
| Jan 2016 | Funding round · Series A | ₹9.02 Cr | Investors: Pharmascience Inc, Mahaganapati Business Advisors LLP , an individual |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Accusoft Technologies Private Limited |
Full deal history
All 31 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Maiva Pharma Private Limited
Maiva Pharma Private Limited has 51 court cases on record: 32 filed by Maiva Pharma, 14 filed against it, 5 where it is another party. 4 cases are pending and 47 are disposed. Status as checked between 30 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 49 | 12 | 4 |
| District courts | 2 | 2 | 0 |
Cases on record (5 of 51)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (SS) | Filed by the company against Klenzaids Aseptic Technologies Private Limited | Disposed |
| District court, BENGALURU, Karnataka | Criminal case | Filed against the company by Srinivas Fine Arts Private Limited | Disposed |
| Madras High Court | Interim or miscellaneous application | Filed against the company by an individual | Pending |
| Madras High Court | Interim or miscellaneous application | Filed by the company against Assistant Commissioner of Labour | Pending |
| Madras High Court | Writ petition | Filed by the company against Assistant Commissioner of Labour | Pending |
Full case history
All 51 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Maiva Pharma Private Limited
Maiva Pharma Private Limited has 14 MSME Form 1 returns on record between 2019 and 2023, listing 134 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Omega Scientific Instruments Private Limited | •••• | •••• | •••• |
| Peenya Industrial Gases Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Creations | •••• | •••• | •••• |
| Mack Pharmatech Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 14 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Maiva Pharma Private Limited
Maiva Pharma operates one associated brand: Maiva Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Formulation development, analytical validation, and injectable supplies are provided. | maivapharma.com |
Employees and EPFO Compliance at Maiva Pharma Private Limited
Maiva Pharma Private Limited has a workforce of 751 employees as of Apr 03, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Maiva Pharma Private Limited
Maiva Pharma has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Maiva Lifesciences Private Limited | U24110TN2022PTC154153 | Locked |
Showing major subsidiaries. Total: 1.
Name History of Maiva Pharma Private Limited
Maiva Pharma has undergone 4 name changes throughout its history. The current legal name is Maiva Pharma Private Limited.
| Company Name | Status |
|---|---|
| Maiva Pharma Private Limited | Current |
| Carodian Private Limited | Previous |
| Global Pharmatech Private Limited | Previous |
| Mablecure Private Limited | Previous |
| Global Parenterals Private Limited | Previous |
News related to Maiva Pharma Private Limited
Recent Activity on Maiva Pharma Private Limited
Maiva Pharma Private Limited has 29 board changes on record since 2007: 6 appointments and 23 cessations. The latest: Buggana Hariharnath ceased to be Additional Director on 05 Nov 2024.
34 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Maiva Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maiva Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maiva Pharma Private Limited
Maiva Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAACG5033G1Z4 | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maiva Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maiva Pharma Private Limited
Maiva Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 February 1993 (33+ years old) and is registered under CIN U24231KA1993PTC013976.
Maiva Pharma reported revenue of ₹399.05 Cr for FY 2025 (up 38% YoY).
Maiva Pharma has 5 current directors:
- Arumugam Bhaskar Krishna - Managing Director
- Janardhan - Whole-Time Director
- Nirav Vinod Mehta - Director
- Buggana Hariharnath - Director
- Vaibhav Bagri - Director
Maiva Pharma reported a net profit of ₹77.08 Cr (net margin 19.3%) and EBITDA of ₹127.3 Cr (EBITDA margin 31.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Maiva Pharma is 34% over three years and 49% over five years. In the latest year (FY 2025) revenue rose 38%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Maiva Pharma is 33AAACG5033G1Z4, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Maiva Pharma is U24231KA1993PTC013976. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maiva Pharma has 51 court cases on record: 32 filed by the company and 14 filed against it. 4 are pending. Most are in the high courts.
Maiva Pharma was incorporated on 05 February 1993, making it 33+ years old. It is registered with the Registrar of Companies, Bangalore.
Maiva Pharma has 31 deals on record (20 secondary share transfers, 11 funding rounds), with disclosed funding of ₹482.8 Cr; the latest was in June 2024.
The peers of Maiva Pharma by revenue are Mascot Health Series Private Limited, Torque Pharmaceuticals Private Limited, Steril-Gene Life Sciences Private Limited, Zeiss Pharmaceuticals Private Limited, Gland Chemicals Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Buggana Hariharnath ceased to be Additional Director on 05 Nov 2024. Vaibhav Bagri ceased to be Nominee Director on 05 Nov 2024. Buggana Hariharnath was appointed as Director on 13 Sep 2024. Maiva Pharma has 29 board changes on record in total.